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Abstract
For more than three decades, both medical professionals and the public have worried that many 
patients receive non-beneficial care in US intensive care units during their final months of life. 
Some of these patients wish to avoid severe cognitive and physical impairments, and protracted 
deaths in the hospital setting. Recognising when intensive care will not restore a person’s health, 
and helping patients and families embrace goals related to symptom relief, interpersonal 
connection, or spiritual fulfilment are central challenges of critical care practice in the USA. We 
review trials from the past decade of interventions designed to address these challenges, and 
present reasons why evaluating, comparing, and implementing these interventions have been 
difficult. Careful scrutiny of the design and interpretation of past trials can show why improving 
goal concordant care has been so elusive, and suggest new directions for the next generation of 
research.
Introduction
For at least 30 years, medical professionals have worried that too many US citizens receive 
non-beneficial treatments in intensive care units (ICUs) at the end of life.1 The citizens’ fear 
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that they will be unable to avoid such treatment helped to fuel the Patient Self Determination 
Act of 1990,2 the legally-recognised physician orders that can be carried around by citizens 
as protection against unwanted treatment (ie, the Physician Orders for Life-Sustaining 
Treatment document and the Maryland Medical Order for Life-Sustaining Treatment 
document),3 and access to physician aid in dying.4 Despite these concerns and efforts, the 
proportion of older Americans (>65 years) who were admitted to an ICU during their last 
month of life increased steadily from 24% to 29% between 2000 and 2009,5 and has not 
changed substantially since.6 By comparison, only 10% of Canadians and 4% of Germans 
are admitted to an ICU during the last month of life.7 This difference is especially 
pronounced in older people. In 2001, 32% of Americans aged 85 years or older who died in 
hospital were treated in a medical ICU during their terminal hospitalisation, compared with 
2% in England.8
Most people agree that avoiding burdensome and invasive treatments is emotionally 
preferable to withdrawing them.9,10 But there will always be patients for whom the benefit 
of life support is uncertain, and a trial of intensive care is appropriate. For these patients, the 
question becomes how long ICU care should continue if the patient is not recovering. The 
conflicting desires to both try treatments with uncertain benefit while simultaneously 
avoiding a medicalised death seem inherent to being an American. A study of first and 
second generation immigrants to the USA with terminal cancer found that those with higher 
levels of US acculturation were more likely to receive chemotherapy, more likely to 
participate in trials, and also more likely to report that they did not want to die in an ICU, 
than those with lower levels of US acculturation.11 Such patients who wish to try therapies 
of uncertain benefit and also avoid a protracted death, rely on physicians to point out when 
continuing treatment might preclude their ability to live, or to die, in a way they value. 
Recognising these pivotal decision points, and helping patients and families who are not 
benefitting from ICU care embrace achievable goals related to symptom relief or spiritual 
fulfilment, is arguably one of the most challenging procedures in critical care.12
In this Series paper, we describe research centred on ensuring that adult patients admitted to 
ICUs in the USA receive care consistent with their values and goals. We propose that these 
complex interventions designed to promote behavioural change present challenges to 
evaluating and comparing their effectiveness. We highlight both systems and cultural factors 
that affect their implementation. Finally, we discuss ideas for aligning ICU care with patient 
goals that are yet to be tested but might herald new and innovative directions for the field.
The legacy of the SUPPORT trial
The landmark SUPPORT trial13 published in 1995 was a pioneering study in the field. In 
their 2-year, prospective cohort study enrolling more than 8000 seriously ill hospitalised 
patients, the SUPPORT trial investigators found that providing physicians with prognostic 
estimates about short-term and long-term outcomes had no effect on the proportion of 
patients asked about their preference for cardiopulmonary resuscitation, length of ICU stay, 
incidence or timing of Do Not Resuscitate orders, or the use of mechanical ventilation 
before death. Although disheartening, the SUPPORT trial allowed the field to reject the 
hypothesis that dying patients are over-treated because intensivists are unaware of their 
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prognoses. Since the SUPPORT trial, the predominant hypothesis has been that the 
modifiable variable causing over treatment of patients in the ICU is infrequent or poor-
quality communication between physicians working in the ICU and patient families. More 
recently, interventions to foster goal-concordant ICU care14 have generally sought to 
increase the frequency and quality of communication between physicians and families 
during multidisciplinary ICU family meetings. Our search for peer-reviewed research 
published in the past decade that evaluated interventions to improve communication between 
US physicians and adult patients in the ICU or their families published in the past decade 
illustrates the diverse ways that this hypothesis has been tested.
Selected studies of communication interventions using pre-post designs
Pre-post study designs have been useful for testing approaches to improving communication 
with families of patients in the ICU (appendix). The study by Mosenthal and colleagues15 
provided no new training for the ICU’s existing staff. Instead, new personnel including 
palliative care physicians, nurses, and bereavement counsellors were integrated into the unit 
workflow. These personnel assessed all patients within 24 h of ICU admission during the 
intervention period and asked the patient’s attending physician and nurse about the patient’s 
most probable outcome using a Likert scale with 1 meaning death and 5 meaning 
independent functional recovery. Regardless of the attending physician’s response, a family 
meeting led by the attending physician was encouraged within 72 h. By contrast, the 
approach taken by Hatler and colleagues16 provided existing ICU staff with 4 h of training, 
introduced no new personnel, and focused only on patients with ICU stays of 7 days or 
longer, or who had been mechanically ventilated for 96 h or more. Finally, a 2010 pre-post 
study by Daly and colleagues17 provided both formal training for existing staff and 
incorporated a dedicated advance practice nurse into each participating ICU. These advance 
practice nurses made no attempt to alter physician communication styles or direct decisions, 
but worked to schedule multidisciplinary family meetings that included the attending 
physician within 5 days of ICU admission for all patients with 72 h or more of mechanical 
ventilation.
Despite their different approaches, these three interventions affected patient care similarly. 
None of them resulted in significant changes in ICU or hospital mortality or in the 
proportion of patients with Do Not Resuscitate orders. However, the mean length of hospital 
stay decreased significantly from 21 days to 15 days in Hatler’s cohort,16 and was reduced 
by half among decedents in Mosenthal’s cohort15 from 14 days to 7 days. Interestingly, the 
effect on patients in the Daly cohort17 appeared to be mediated by ICU type. For example, 
the proportion of patients in surgical ICUs receiving a tracheostomy before death was stable, 
but among 50 decedents in medical ICUs, tracheostomy dropped from 6 (55%) of 11 
patients to 5 (13%) of 38 patients. Process measures provided relatively few hints about the 
mechanisms driving these changes. However, Mosenthal and colleagues15 reported that 
whereas the proportion of patients with a family meeting did not change (62% before vs 
60% after), goals of care discussions during rounds increased from 32 (4%) to 313 (36%), 
suggesting that the content of conversations within the clinical team, rather than the 
incidence of contact between clinicians and families, might have driven the observed 
changes.
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Randomised trials of ICU communication interventions
At least four multi-site trials of communication interventions involving family meetings 
were done in US adult ICUs between 2008 and 2018 (table 1). Trial designs and a 
description of the interventions are summarised in the appendix. Inclusion criteria varied, 
but three trials19–21 targeted the families of mechanically ventilated patients who received at 
least 24 h of ICU care and had poor long-term prognoses, whereas the trial from 2011 by 
Curtis and colleagues18 measured outcomes among families of patients who died during an 
ICU stay and those who died within 30 h of transfer to another hospital location.
As with the earlier pre-post studies,15–17 the personnel used in the trial interventions varied. 
The 2011 trial by Curtis and colleagues18 introduced no new personnel, a palliative care 
physician and nurse practitioner led family meetings in the 2016 trial by Carson and 
colleagues,20 and specially trained ICU nurses and social workers facilitated meetings led by 
ICU attendings in the 2016 trial by Curtis and colleagues19 and in the trial by White and 
colleagues.21 Additional training for existing ICU clinicians ranged from none19,20 to 
multiple in-person education sessions in each ICU.21 The timing and frequency of 
interactions with family members also differed across studies. Mechanically ventilated 
patients with a sequential organ failure assessment score of 6 or higher, or at least a 30% 
chance of hospital mortality, were approached by communication facilitators as early as 24 h 
after admission in one trial.19 Whereas patients did not become eligible for an intervention 
meeting until they had been mechanically ventilated for at least 7 days in another.20 
Although fidelity to the intervention protocol was unclear in some cases, the protocol in 
2018 by White and colleagues21 included the largest planned dose of contact, consisting of 
families meeting with interventionists daily, and participating in a family meeting led by the 
attending physician within 48 h of enrolment.
Analysis and results of these four trials are presented in the appendix. All studies enrolled 
family members of adult patients in the ICU with total enrolment ranging from 268 family 
members to 1106 family members, and cohort retention ranging from 46% (396 assessed out 
of 822 enrolled)18 to 73% (809 assessed out of 1106 enrolled).21 The 2011 trial by Curtis 
and colleagues18 used the validated Quality of Death and Dying scale22,23 as the primary 
outcome, whereas the other trials used validated instruments for assessing mental health 
symptoms. Enrolled families were assessed between 4 weeks and 6 months after ICU 
discharge. All trials estimated the effect of being randomised to the intervention group (ie, 
intention-to-treat analysis) using multivariable generalised linear regression.
None of the trials reported a significant change in reports by family members of symptoms 
of depression, anxiety, or post-traumatic stress except for less frequent depression symptoms 
measured at 6 months in the 2016 trial by Curtis and colleagues,19 and an increase in post-
traumatic stress symptoms in the 2016 trial by Carson and colleagues.20 The trial by White 
and colleagues21 was the only intervention with a statistically significant effect on hospital 
mortality which rose from 264 (30%) of 873 patients in the control group to 208 (38%) of 
547 patients in the intervention group. Interventions integrating trained interventionists into 
daily work flows changed the length of stay significantly. The 2016 trial by Curtis and 
colleagues19 and the 2018 trial by White and colleagues21 both observed significant 
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decreases in mean hospital length of stay for all patients; ICU length of stay among patients 
who died during an ICU stay dropped precipitously from 29 days to 8 days in the trial by 
Curtis and colleagues,19 and from 7 days to 4 days in the trial by White and colleagues.21 
However, changes in mortality were not consistent. The intervention group had lower 
mortality than the control group in the trial by Curtis and colleagues,19 but higher mortality 
than the control group in the trial by White and colleagues.21
The consistent association between early, structured communication by the ICU team and 
decreased length of stay in these trials is unsurprising. Purposeful, structured communication 
with critically ill patients and their families has been associated with decreased length of 
stay for at least 15 years.24 But how this association is interpreted is contentious. Sceptics 
worry that decreased length of stay, particularly paired with higher in-hospital mortality, is a 
sign that clinicians in the intervention group of the trial inappropriately pressured families 
into withholding or withdrawing life-support from patients who would have preferred to 
continue treatment. Supporters point to the same data as evidence that when clinicians 
disclose prognosis and inform patients and families that they have the option of avoiding or 
stopping life-support technology early in an ICU stay, a substantial portion freely choose to 
do so, even when that means dying sooner. Currently, interpreting the association between 
early communication and length of stay serves as a test that shows much about the viewer’s 
beliefs about doctors and the citizenry. Qualitative work might help to clarify which of these 
interpretations reflect reality.
Communication interventions as behaviour change campaigns
The different interventions evaluated in the past decade reflect the tools at hospitals’ 
disposal when advocating for changes in practice (figure 1). The 2011 trial by Curtis and 
colleagues18 using grand rounds presentations, videos that are easily incorporated into 
online teaching modules, and educational pamphlets, is emblematic of low-cost, quality 
improvement campaigns commonly used across large health systems. Such campaigns 
assume the primary barrier to change is insufficient awareness or familiarity,25 and provide 
information or training but no new personnel. By contrast, the 2016 trial by Carson and 
colleagues20 encapsulates the way ICUs in hospitals with a new palliative care service 
sometimes operate. In this trial, palliative care providers were people employed outside of 
the core ICU team who met with families once or twice about patients who were not 
recovering despite more than a week of ICU care. Importantly, ICU attendings participated 
in only 10 (9%) of 116 family meetings led by these palliative care specialists. Neither the 
awareness-raising campaign nor the late introduction of an outside team had any significant 
effect on patient outcomes, and post-traumatic stress symptoms were marginally worse 
among families randomly assigned to a palliative care-led family meeting.
By contrast, the trials by Mosenthal,15 Curtis,19 and White,21 and their respective colleagues 
integrated personnel with new roles and additional training into the existing ICU team. In the 
trial by White and colleagues, interventionists were nurses who were hand-selected by the 
ICU director, thus ensuring that they were familiar faces trusted by the ICU leadership. In 
each of these studies, interventionists were responsible for preparing families to speak with 
physicians, and for scheduling multidisciplinary family meetings led by ICU attendings. In 
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both trials,19,21 the initial contact between interventionist and family often happened within 
24 h of admission, and a first family meeting occurred within 2–3 days of eligibility. The 
interventionists did not provide the attendings with new information or attempt to influence 
the options presented to families. Rather, they assumed that the attendings possessed the 
knowledge and attitudes required for high-quality communication and removed external 
family and environmental barriers to meetings (ie, coordinated everyone’s schedules to make 
both time and space for meetings).25
Challenges in the design and interpretation of ICU communication studies
Designing and interpreting evaluations of communication interventions in the ICU is 
difficult for at least six reasons (panel). First, most critically ill patients are too ill to 
participate in a research study. Some patients are too ill to complete surveys at discharge or 
follow-up, and a substantial proportion die before hospital discharge. These circumstances 
mean that even the most rigorous study doesn’t have adequate feedback from the most 
important person potentially affected by the intervention, and instead rely on reports from 
their family members or surrogate decision-maker. Second, there is no clear consensus on a 
target population. Previous studies have attempted to enrol patients at high risk of death or 
long-term functional impairment by limiting enrolment to patients with a minimum duration 
of mechanical ventilation. This strategy excludes patients with short but potentially 
traumatic ICU stays. Other studies have enrolled patients whom attendings believe have a 
risk of death of higher than 30%.19,21 This approach ensures that attending physicians agree 
that a directed effort at high-quality communication is appropriate for the families in the 
study. However, physician predictions about in-hospital mortality are deeply imperfect.26,27 
Moreover, this approach re-enforces the idea that structured communication with families is 
only necessary if patients are at high risk of death despite a substantial body of research 
showing that patients who survive after a stay in the ICU often experience new, long-lasting 
impairments28,29 and their family members are at increased risk of long-term depression.30 
Third, enrolling a representative sample of family members can be challenging. Laws about 
who is authorised to make medical decisions for an incapacitated patient vary greatly across 
the 50 states in the USA.31 To further complicate matters, clinicians often speak to 
whichever family member is present at the bedside when consent or input is desired. To 
reflect this reality, most trials enrol English-speaking family members who are present and 
engaged in clinical decision-making regardless of their legal authority. Study cohorts 
assembled using these criteria are representative of the families of patients in the ICU who 
are available for family meetings; however, the patients of enrolled families might not be 
representative of the ICU’s patient population. Daily attempts to enrol family members of 
284 eligible patients in one ICU found that only 38% of the eligible patients had an enrolled 
family member after 7 days of screening, despite 92% of approached families agreeing to 
participate.32 The patients with an enrolled family member were significantly more likely to 
be white and to live in a wealthy neighbourhood. Poorer patients were less likely to have a 
family member at their bedside. Although not well studied, this setting might be because 
poorer families are less likely to have access to transportation and the ability to miss work 
without risking wage or job loss. In a past trial,33 families of patients in the ICU who 
received palliative care were also more likely to respond to follow-up surveys, introducing 
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response bias. Most studies do not enrol families with limited English proficiency. A study 
from 2018 of decedents in one hospital found that it took an average of 19 days longer for 
patients with limited English proficiency to transition to care focused on comfort compared 
with English-speaking patients after adjusting for differences in education and insurance 
status.34 These challenges make it difficult to forecast how communication interventions 
might affect care in ICUs serving diverse or disadvantaged populations. Fourth, 
randomisation levels vary and blinding is nearly impossible in clinical trials of 
communication interventions. Investigators have thus far randomly assigned patients in the 
ICU,19 patient–family dyads,20 ICUs,21 and entire hospitals.18 Random assignment of 
individual patients is imperfect because most interventions seek to change an aspect of 
physician behaviour (eg, if and when physicians call family meetings, what families are told 
during meetings, etc). Once learned or adopted, such behaviours are difficult to stop when 
interacting with families randomised to usual care. Random assignment of clinicians is 
possible, but patients in the ICU with more than a few days stay are rarely treated by a single 
clinician, which prevents inferences about the intervention’s effect on patient outcomes. 
Unlike exposure to a pill whose effects can be isolated, attitudes and behaviours tend to leak 
within a population. Cluster randomised trials, including stepped-wedge trials, are an 
appropriate design choice under these conditions.35 However, the trade-off inherent in a 
cluster-randomised design is efficiency. Because patients within a cluster are correlated, they 
each contribute less unique information. This correlation within a cluster decreases the 
effective sample size, the precision of treatment effect estimates, and the power of the trial.36 
Fifth, ICU communication initiatives are complex interventions with interacting components 
targeting the behaviours of both clinicians and families.37 Embedding process evaluation 
within trials of complex interventions, as recommended by the UK Medical Research 
Council, can provide insight into causal mechanisms, reproducibility, implement ation 
fidelity, and contextual factors associated with outcomes.38 When conversations are the crux 
of an intervention, knowing what was said, what was understood, when, and by whom, is 
vital to the process evaluation. For now, there is no validated way to quantify the timing and 
intensity of communication that occurs between ICU proxies and the team. To carry forward 
the pill analogy previously mentioned, investigators are minimally able to determine the 
number of milligrams administered (ie, frequency of meetings and basic content of 
discussion) but are unable to determine the bloodstream concentration of the drug (ie, how 
the communication was perceived by the surrogate decision-maker). As a result, families of 
patients with similar lengths of stay can receive radically different doses of communication 
(figure 2); and, more problematic, investigators have few measures for dose or uptake.
Recording family meetings can help to address this problem, but many interactions with ICU 
proxies take place outside formal meetings, permission to record family meetings is tricky to 
obtain, and recordings do not always capture the emotional temperature of a meeting. 
Although family meetings have successfully been audio recorded in past studies,39,40 the 
families and clinicians who consent to recordings are likely to be different from those who 
do not, and the act of recording introduces the Hawthorne effect by which study participants 
behave differently when they are aware of being observed or recorded.41 As a result, we 
usually do not know what transpires in family meetings or which components of 
communication interventions were most effective. For example, did the length of stay 
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decrease in the 2018 trial by White and colleagues21 because family meetings were 
scheduled sooner, or because physicians presented different treatment options, or because 
families asked different questions as a result of the question prompt lists. Without data from 
the room where it happens, we do not know.
Finally, the greatest challenge in studies of communication interventions is selecting an 
appropriate primary outcome. The ideal intervention would prevent both undertreatment and 
overtreatment, decrease the moral distress of clinicians, improve the mental health of family 
members, and require minimal time, effort, and money. That is a difficult task that cannot be 
assessed using a single outcome measure. Although patients should be the first priority, the 
field does not have a validated method for assessing whether patients are receiving goal-
concordant care.14,42 Patient goals, such as being well enough to live at home, living long 
enough to witness a birth or wedding, or being comfortable, often change over the course of 
a life and the course of an ICU stay, and are rarely recorded in the medical record. And 
when a patient’s goals are known, agreement among intensivists about whether treatments 
could help to achieve them is only moderate.43 For these reasons, patient-centred outcomes 
in trials of communication interventions have usually been limited to mortality and length of 
stay.
Communication interventions have resulted in decreased length of stay without a substantial 
change in hospital mortality across multiple studies, which supports the hypothesis that poor 
communication contributes to over-treatment. It also suggests that holding high-quality 
family meetings earlier during an ICU stay speeds up a process whose outcome is 
foreordained. This interpretation has been comforting for clinicians who fear that telling 
patients and families about the option of withdrawing life-support will result in avoidable 
deaths. However, this interpretation is challenged by the 2018 trial by White and 
colleagues21 in which families randomly assigned to the intervention perceived their loved 
ones as receiving more patient-centred care, their doctors as more skilled communicators, 
and there was a significant 8 percentage points increase in hospital mortality.21 Crucially, the 
trial also found no significant difference in 6-month mortality or the proportion of patients 
living independently in their homes 6 months later.21 One interpretation is that the 
intervention allowed families who believed their loved one would prefer dying in the 
hospital to spending their last weeks or months in a residential facility to voice that opinion, 
and influence treatment decisions that might have resulted in an earlier death but not 
necessarily a worse or avoidable one.
Given the difficulty of assessing patient outcomes, communication trials have used the 
mental health symptoms of surrogate decision-makers of patients in the ICU 3–6 months 
after discharge of the patient as their primary outcome. Inherent in this decision is a belief 
that the long-lasting anxiety, depression, and post-traumatic stress experienced by some 
surrogate decision-makers of patients in the ICU44 regardless of whether the patient 
survives, stems from insufficient emotional support during the surrogate decision-making 
process. There is evidence suggesting that this hypothesis might be true. For example, a 
secondary analysis of more than 300 surrogate decision-makers found only high baseline 
anxiety and depression, and patient unresponsiveness on day 10 of mechanical ventilation 
were associated with post-traumatic stress symptoms in surrogate decision-makers 3 months 
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later.45 Day 10 of mechanical ventilation is a common clinical crossroad. One hypothesis is 
that surrogate decision-makers of unresponsive patients on day 10 were asked to choose 
between a tracheostomy and withdrawing ventilator support, and developed post-traumatic 
stress symptoms as a result of this decision. But there is also reason to think that one 
potentially modifiable cause of the mental health symptoms of families of patients in the 
ICU is not the burden of surrogate decision-making, but their lack of control over their loved 
one’s medical care. In qualitative interviews, surrogate decision-makers have described their 
decision to limit or stop life-support as allowing them to regain a sense of power and control 
that eased the feelings of helplessness that they experienced while witnessing their loved 
one’s ICU care.46 Feelings of helplessness and frustration are not uncommon. In a survey of 
1495 surrogate decision-makers of patients in the ICU, 856 (57%) reported they had poor 
control over the care their family member was receiving.47 Informing families that they can 
direct care to be focused on comfort, longevity, or some other goal early in the course of an 
ICU stay, rather than after the clinical team feels certain that the patient is unlikely to 
recover, might help to alleviate or shorten this period of perceived helplessness. Given the 
conflicting evidence on how surrogate decision-makers respond to their decision-making 
authority (ie, does it cause psychological harm, or does it protect them against feelings of 
helplessness?), assessing what role family members wish to have in the decision-making and 
responding accordingly is essential for physicians. This task means both ceding control 
when surrogate decision-makers prefer choosing independently between acceptable 
treatment options, and assuming responsibility when surrogate decision-makers ask 
physicians to make difficult decisions as described in the policy statements of American 
critical care societies.48
Interventions tested thus far have not had a substantial effect on the mental health outcomes 
of surrogate decision-makers for patients in the ICU. Trials have also struggled with loss at 
follow-up. This trend is not surprising given that attrition rates are normally about 25% in 
clinical trials evaluating treatments for post-traumatic stress syndrome.49,50 Because 
avoidance is a hallmark of this disorder, surrogate decision-makers with post-traumatic 
stress symptoms might be more likely to drop out of a study that asks them to recall a 
traumatic experience, thereby raising the possibility of selection bias.51 Finally, it is unclear 
what degree of depression and anxiety is appropriate or normal among surrogate decision-
makers of patients in the ICU. Given that a substantial proportion of families are bereaved, 
and families of patients surviving an ICU stay often face decreased employment,52 new 
caregiving demands, and financial stress,53 some increase in anxiety and depression 
symptoms might be expected in this population. For all these reasons, mental health 
symptoms of a surrogate decision-maker are not ideal outcomes for ICU communication 
trials. However, until there is a strong, validated, alternative metric, these outcomes will 
probably still be used.
Obstacles to implementing goal-concordant ICU care
Clinical practice patterns in ICUs are shaped by cultural norms. Both US geographical 
regions,54 and institutions55–58 vary widely in their approach to caring for patients at the end 
of life. Research informed by behavioural psychology and sociology suggests cultural and 
contextual influences might help to explain this variety. For example, the term clinical 
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momentum59 has been used to describe the combination of recognition-primed decision-
making,60 the cascade effect,61 and sunk cost effects.62,63 Clinical momentum posits that 
both patients and clinicians view medicine’s role as restoring normal physiological function, 
even when changes in physiology are a normal part of ageing and dying. Clinicians are 
trained (or primed) to recognise such physiological deviations and rewarded for quickly 
matching them to diagnostic tests or treatments. These tests and treatments in turn can cause 
complications or pain, which then trigger further treatments, setting off a cascade of 
interventions, each of which is an irretrievable investment of time, effort, and money. Thus, a 
perceived obligation to repair a physiological abnormality can set a process in motion that 
continues without consideration for long-term consequences.
Although the long-term consequences of treatment might not be the primary consideration 
of most clinicians in the ICU, they are essential to patients. Older patients (>60 years) with 
cancer, congestive heart failure, and chronic obstructive pulmonary disease prefer treatments 
with high potential for an adverse outcome of death to a high potential for functional or 
cognitive impairment.64 Yet, these patients are routinely admitted to ICUs even though 
surviving an ICU stay frequently results in new or worsening physical28,65 or cognitive29,66 
impairment. Scarce knowledge among older patients and their families about the long-term 
outcomes of critical illness contributes to this incongruous decision. In audio-recorded 
family meetings, intensivists discussed the long-term quality of life in only 52 (45%) of 116 
meetings,67 and long-term physical and cognitive function in 9 (12%) of 71 meetings,68 with 
most meetings focused instead on the patient’s current condition and descriptions of 
diagnostic or life-prolonging treatment options.69 Among the factors making intensivists 
hesitant to discuss long-term outcomes are scarcity of contact with patients beyond ICU 
discharge, discomfort expressing uncertainty,70 and even the belief among some clinicians 
that long-term outcomes should not influence decisions.71
American culture, politics, and history also have a role in the cause of clinician discomfort 
in discussing long-term prognosis and advance care planning. The medical community’s 
history of discrimination against racial minorities, including segregated health-care facilities 
and unethical clinical research,72,73 has ongoing consequences. Black and Hispanic citizens 
report greater distrust in health-care professionals than do white Americans.74 American 
intensivists, most of whom are white or Asian75 and aware of this history, might spend days 
trying to build trust with families in minority groups before they feel comfortable saying 
anything that could be interpreted as advocating for limiting treatment. Also, in an attempt to 
erode support for the Patient Protection and Affordable Care Act, which was signed into law 
in 2010, many Americans were misled to believe that the law would result in doctors or 
politicians denying treatment to older patients on the basis of cost.76 In this distrustful 
milieu, it is understandable that some intensivists are unnerved when disclosing a poor long-
term prognosis.
The fact that intensivists are nervous about disclosing long-term prognosis does not mean 
that providing patients and their surrogate decision-makers with information about long-term 
outcomes and encouraging them to state their opinions will necessarily change current 
practice. Physicians rarely elicit information about patient treatment preferences,77 and 
silence from well informed patients and surrogate decision-makers cannot be interpreted to 
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mean they are receiving appropriate care. This behaviour is because families fear that 
expressing a preference for less aggressive treatment, or even pointing out a potential 
mistake, will get them labelled a troublemaker or a difficult patient.78–80 It is also naive to 
assume that when patients and surrogate decision-makers do speak up, their preferences 
affect care. On the contrary, preferences and values voiced by patients and surrogate 
decision-makers have no effect on when physicians permit patients to transition to end-of-
life care, as shown in both clinical vignettes and longitudinal cohort studies.81,82 In this 
setting, telling patients and surrogate decision-makers that they can prevent overtreatment by 
simply speaking about their values in family meetings is disingenuous. Relying on surrogate 
decision-makers to prevent overtreatment or slow clinical momentum is also not a solution 
because up to 27% of patients in some ICUs do not have any surrogate decision-maker.83,84
When physicians present the option of care focused on comfort, this presentation is strongly 
influenced by the ethos of their specialties.85,86 The most well documented example is in 
surgery, in which many surgeons believe that they obtain permission to dictate the duration 
of post-operative ICU care on the basis of informal preoperative discussions.87–89 Reporting 
metrics, such as 1-year survival after organ transplant, can also motivate physicians’ timing 
of discussions about end-of-life care.90,91 These beliefs and metrics are deeply entrenched 
aspects of practice for many specialists that are improbable to change without purposeful 
effort from within these subspecialties.
Nurses, who occupy an intermediary position in ICU communication, cannot prevent 
overtreatment alone. Because nurses are omnipresent at the bedside, patients in the ICU and 
their families frequently share their goals, concerns, and questions with them. Nurses 
perceive relaying these statements to physicians and advocating for appropriate care on 
behalf of patients as essential to their professional role.92 However, nurses working in the 
ICU are generally not authorised to discuss prognosis or palliative care with patients and 
families.93 So although nurses working in the ICU might understand the concerns and 
motivations of both patients and physicians, they are generally intercessors empowered to 
move information in only one direction.
Finally, surveys suggest ICU providers in the USA often continue life-support even when 
they perceive it to be inappropriate.94 The umbrella term of potentially inappropriate is used 
to encompass both requested treatments that are not expected to help with achieving a 
patient’s goal, and treatments that will help to achieve a goal of questionable value to the 
medical team, such as being alive with end-stage dementia and multiple organ failure. In 
2015, critical care professional societies endorsed a process-based approach to resolving 
disputes in these situations.95 This seven-step process involves enlisting consultants skilled 
in mediation, obtaining second opinions, involving an interdisciplinary hospital committee 
in conflict resolution, and giving patients the opportunity to transfer to another hospital or 
engage the legal system. To be effective, hospitals must adopt the policy, support clinicians 
who initiate the process, and maintain an interdisciplinary committee who can respond 
promptly and efficiently to requests for mediation. If clinicians perceive the dispute-
resolution process to be more time-consuming and burdensome than simply continuing to 
provide inappropriate care, it is unlikely to be invoked. The extent to which this process is 
used is unknown, and its effect on patient care is unclear.
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Recommendations for future research
Investigators will continue to trial interventions in this field, particularly given the National 
Heart, Lung, and Blood Institute’s programme announcement in January, 2019, supporting 
research that uses practical approaches to increase the uptake of shared decision-making, 
including in the ICU setting (programme announcement number PA-19–166).96 We have six 
recommendations that are likely to be applicable to many of the studies funded as a result. 
First, recognise that most initiatives in this field are very complex behavioural interventions 
and collect as much data as possible on process evaluation and implementation fidelity. 
Second, eligibility for interventions designed to ensure that patients receive appropriate, 
goal-concordant care should not be defined by whether clinicians expect the patient to die 
during the admission. Defining eligibility this way re-enforces the misconception that 
engaging families in shared decision-making is only necessary when the clinical team 
believes the patient is actively dying. This criterion also excludes a considerable subgroup of 
dying patients, given physicians’ limited ability to prognosticate survival to discharge, 
particularly early in an ICU stay.26 Third, always assess the representativeness of the 
enrolled study sample and how loss to follow-up might have biased effect estimates in 
longitudinal cohort studies. Fourth, seek to measure both the dose of the intervention 
received, and the effect of that dose on patient and family perceptions. Fifth, treat the 
clinician leading family meetings as a confounding variable. The risk-adjusted mortality of 
mechanically ventilated patients varies according to which physician cares for them and this 
variability is not explained by a physician’s previous experience managing mechanically 
ventilated patients.97 Given that clinicians are unlikely to be balanced across treatment 
groups, this imbalance makes the clinician a confounding variable in most causal models. 
Finally, consider collecting data on how the multi-society process-based approach to dispute 
resolution95 is being used.
Future directions and potential innovations
Efforts to match the care that patients receive in ICUs with the care they desire motivates 
multiple trials currently underway (table 2). A follow-up to the 2016 trial by Curtis and 
colleagues19 of communication facilitators will focus on engaging patients and surrogate 
decision-makers earlier during their ICU stay and continuing to support them across care 
transitions for months after ICU discharge (). A follow-up to the 2018 trial by White and 
colleagues21 is also planned () and will include audio-recordings of interventionist 
encounters to assess fidelity.98 Both of these trials will use mental health outcomes of 
surrogate decision makers as primary outcomes.
Teams are also doing large pragmatic trials to test whether small changes to the clinical 
decision-making environment, or so-called nudges, can improve ICU care.99 The 
Randomized Evaluation of Default Access to Palliative Services (REDAPS) study aims to 
enrol between 12 000 and 15 000 patients aged 65 years or older with a diagnosis of 
advanced chronic obstructive pulmonary disease, end-stage renal disease, or dementia and a 
hospital stay of at least 72 h.100 A default order for a palliative care consult will be created 
for all patients during the intervention phase of the trial. A similar trial called PONDER-ICU 
() will enrol 4750 patients in the ICU with at least 24 h of mechanical ventilation across ten 
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hospitals, and test two behavioural economic interventions.99 Under the first intervention, 
physicians working in the ICU will be asked in the patient’s electronic medical record if 
they have offered the option of care focused on comfort and be required to provide 
justification if they answer no. An important strength of this approach is that it does not 
require adding personnel to the clinical team, or require existing clinical staff to 
spontaneously recognise which of their patients might benefit from a palliative approach to 
care.
The second intervention requires physicians to estimate patients’ mortal and functional 
outcomes before signing future orders, thus concentrating their attention on long-term 
outcomes. The second intervention leverages the focusing effect, which describes the human 
tendency to give more weight to elements of choices that are being prompted to be 
considered,101,102 and was shown in a randomised trial81 of US intensivists reviewing 
clinical vignettes online. Previous studies by Mosenthal and colleagues,15 Curtis and 
colleagues,19 and White and colleagues21 all involved study personnel asking attendings 
about prognosis, thereby incorporating prompting into their interventions without explicitly 
identifying it as such. However, one study calls into question whether a prompt is sufficient 
to change the options ICU proxies are offered. In a double-blind, randomised controlled 
trial103 done in a high-fidelity simulation centre, intensivists prompted to document 
prognosis were significantly more likely to disclose that the patient was sick enough to die 
during a simulated family meeting than those who were not prompted to document 
prognosis, but no more likely to tell the patient’s daughter that care focused on comfort was 
an option.104
Change might also come from unexpected directions. For example how new ICU follow-up 
clinics might affect clinical decision-making is unclear.105,106 If intensivists staff these 
clinics, they will have more direct contact with patients surviving an ICU stay. On one hand, 
seeing the prevalence of cognitive impairment, physical disability, anxiety, and depression 
experienced by patients surviving an ICU stay might give intensivists pause. On the other 
hand, seeing only those patients who are healthy enough to travel to outpatient appointments 
might show a deceptively positive picture of ICU survivorship overall. Other potential 
sources of new information are the increasingly large and publicly available administrative 
databases. Intensivists and families sometimes agree to time-limited trials106–109 of ICU 
care or a specific medical therapy to see if a patient will improve. Administrative data might 
inform these negotiations and complement existing empiric evidence on the long-term 
outcomes of ICU care.110,111
Finally, patients and family members might demand changes that the medical community 
has not anticipated yet. In 2011, more than 16 million US citizens, most of whom were 
middle-aged women, did unpaid caregiving work for elderly relatives.112 These caregivers 
are increasingly dissatisfied with their loved one’s end-of-life care. The proportion of 
bereaved families in the National Health and Aging Trends Study113 who reported their 
loved one received excellent end-of-life care dropped from 353 (57%) of 622 in 2000 to 275 
(47%) of 586 in 2013. Family caregivers are also financially pressured. The cost to a 
daughter’s wellbeing of caregiving for an older parent is estimated to range from US$72 000 
to $100 000 per year.114 As the US population ages, both the number of unpaid family 
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caregivers and the number of people requiring end-of-life care are projected to rise. Whether 
ICUs will change how they treat these patients and families, or whether these patients and 
families will change ICUs, is yet to be seen.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key messages
• Recognising when intensive care unit (ICU) care is not helping a patient 
achieve valued goals, and helping that patient and their family embrace 
achievable goals, related to symptom relief or spiritual fulfilment, are central 
challenges of critical care in the USA
• Randomised trials of complex communication-focused interventions in the 
ICU have not shown substantial effects on the long-term mental health 
symptoms in family members of patients in the ICU, but many of these 
interventions have resulted in a decreased length of stay, particularly among 
study participants who die in hospital
• Numerous design and analysis challenges make interpreting trials of 
interventions that are designed to improve communication between ICU 
providers, patients, and families difficult
• Clinicians and researchers designing and interpreting studies of 
communication interventions should be aware of the deep-seated cultural 
norms and structural aspects of US medical institutions that together 
contribute to Americans receiving substantially more ICU care during their 
final month of life than residents of similarly wealthy nations
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Panel: Challenges in the design and interpretation of intensive care unit 
(ICU) communication studies
(1) Limited ability to collect patient-reported outcomes for investigators
• Some patients are too ill to complete surveys at discharge or follow-up, and a 
substantial proportion of patients die before hospital discharge
(2) No consensus in the field on a target population
• Only enrolling families of patients perceived to be at high risk of death or 
chronic critical illness potentially re-enforces the idea that structured 
communication with families of patients in the ICU is only necessary when 
patients are dying
• Prediction of in-hospital mortality is also imperfect
(3) Enrolling a representative sample of family members is challenging
• Families of patients at highest risk for goal-discordant care are often difficult 
to enrol in research studies
• Families of patients who receive palliative care participate in research at 
higher rates, creating potential response bias
(4) Trade-offs to randomising individuals and clusters of patients
• New behaviours are often adopted by an entire ICU team, making them 
difficult to isolate when individual patients are randomised to treatment
• Cluster randomised trials are appropriate in this context, but decrease a trial’s 
effective sample size and power to detect intervention effects
(5) Steep barriers to process evaluation
• Conversations are the crux of interventions, but data on the content of family 
meetings is difficult to collect
• Obtaining permission to record family meetings can be challenging
(6) No consensus on a primary outcome
• The field does not have a validated method for assessing whether patients are 
receiving goal-concordant care
• In its absence, investigators have focused on multiple surrogate outcomes
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Search strategy and selection criteria
References for this Series paper were identified through searches of PubMed, Embase, 
Cochrane Library, and ClinicalTrials.gov for original articles about interventions 
designed to facilitate communication and decision-making in adult ICU patients and their 
families published from Jan 1, 2008, to August 1, 2018. We used the terms “critical 
illness” and closely related terms in combination with “patient preference”, “family”, 
“communication”, and “randomized controlled trial” and their closely related terms. 
Articles in English identified by these searches and relevant references cited in these 
articles were reviewed. We also included publications accumulated because of our 
participation in this field of research.
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Figure 1: Common elements of interventions designed to improve communication with surrogate 
decision-makers of patients in the ICU
ICU=intensive care unit.
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Figure 2: Communication patterns with ICU proxies about patients with prolonged ICU stays
Panels depict the hypothetical timing and intensity of communication with patient proxies 
(ie, health-care surrogates, health-care agents, or legal guardians, all of which may or may 
not be family members) for a patient without decision-making capacity. 1 denotes 
perfunctory communication (eg, voicemail left) and 10 denotes comprehensive 
communication (eg, multidisciplinary family meeting).
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Table 2:
Ongoing and planned clinical trials of communication interventions in US adult ICUs
Description Primary Outcome
Facilitating communication 
study ()
Follow-up to the 2016 trial by Curtis and colleagues20 of an intervention using 
nurses working in the ICU as facilitators to support, model, and teach 
communication strategies over an illness trajectory, beginning in the ICU and 
continuing to care in the community
Family symptoms of 
anxiety and depression 
(HADS)
The four supports study () Follow-up to the 2018 trial by White and colleagues21 designed to evaluate the 
effectiveness of a multifaceted communication intervention as compared with an 
educational control among family members of critically ill patients; now with 
audio recording of intervention encounters to assess fidelity
Family symptoms of 
anxiety and depression 
(HADS)
Randomised evaluation of 
default access to palliative 
services ()
Large pragmatic trial testing a default order for a palliative care consult for older 
patients (>65 years) with a diagnosis of chronic obstructive pulmonary disease, 
end-stage renal disease, or dementia and a hospital stay of at least 72 h
Composite measure of 
length of stay and in-
hospital mortality
Prognosticating outcomes 
and nudging decisions with 
electronic records in the ICU 
()
Pragmatic, stepped-wedge, cluster randomised trial testing two different 
electronic health record behavioural interventions among seriously ill 
hospitalised patients
Composite measure of 
length of stay and in-
hospital mortality
HADS=hospital anxiety and depression score. ICU=intensive care unit.
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